Search - tctmd.com

Displaying 881 - 900 of 938

Sort: Relevancy | Date

News Industry News

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

July 26, 2011

News Industry News

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

July 26, 2011

News Industry News

OrbusNeich's GenousTM Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery

July 18, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

Bone Marrow Stem Cells Improve Angina Symptoms in Refractory Patients

Jason Kahn

July 07, 2011

News Daily News

Endovascular Intervention Generally Safe in Elderly PAD Patients

June 20, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

Complete Revascularization Irrelevant for Most Multivessel Disease

Caitlin E. Cox

June 03, 2011

News Daily News

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

Caitlin E. Cox

May 27, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Industry News

Tryton Announces Positive Data from Three European Registries

May 20, 2011

News Conference News

Paclitaxel Balloon Maintains Advantage at 5 Years

Caitlin E. Cox

May 20, 2011

News Industry News

One Year Clinical Outcome of the 2000 Patients Enrolled in the Coronary Angioplasty Acute Myocardial Infarction Titan2 Bio Active Stent Registry: The CATS-AMI Registry

May 20, 2011

News Conference News

FFR-Guided Stenting Cost Effective in European Countries

Jason Kahn

May 20, 2011

News Conference News

POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients

Caitlin E. Cox

May 19, 2011

News Industry News

New Data Confirms Safety of BioMatrix™ at One Year

May 19, 2011

News Industry News

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

May 19, 2011

News Industry News

Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future

May 18, 2011

News Industry News

STENTYS Joins Stent for Life Initiative to Expand Optimal Heart Attack Treatment Across Europe

May 18, 2011

News Industry News

A Prospective, Randomised and Multicentre Trial Comparing Titan2 Bio Active Stent (BAS) and Xience V Drug Eluting Stent (DES): The BASE-ACS Trial

May 17, 2011

Advertisement

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

OrbusNeich's GenousTM Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Bone Marrow Stem Cells Improve Angina Symptoms in Refractory Patients

Endovascular Intervention Generally Safe in Elderly PAD Patients

Syntax Score Predicts 1-Year Risk in ACS Patients

Complete Revascularization Irrelevant for Most Multivessel Disease

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Tryton Announces Positive Data from Three European Registries

Paclitaxel Balloon Maintains Advantage at 5 Years

One Year Clinical Outcome of the 2000 Patients Enrolled in the Coronary Angioplasty Acute Myocardial Infarction Titan2 Bio Active Stent Registry: The CATS-AMI Registry

FFR-Guided Stenting Cost Effective in European Countries

POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients

New Data Confirms Safety of BioMatrix™ at One Year

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future

STENTYS Joins Stent for Life Initiative to Expand Optimal Heart Attack Treatment Across Europe

A Prospective, Randomised and Multicentre Trial Comparing Titan2 Bio Active Stent (BAS) and Xience V Drug Eluting Stent (DES): The BASE-ACS Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content